Anteo Diagnostics & Sona Nanotech team up to improve lateral flow tests
Category: #health  By Pankaj Singh  Date: 2019-01-17
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Anteo Diagnostics & Sona Nanotech team up to improve lateral flow tests

* The collaboration aims to help accelerate the development & enhance lateral flow immunoassays’ performance.

* Under the collaboration agreement, Sona’s gold nanorod tech would be merged with Anteo’s AnteoBind and several other biomarkers.

Anteo Diagnostics (Anteo), an Australian nanotechnology firm, has reportedly announced that it has signed a collaboration agreement with Canadian gold nanotechnology company, Sona Nanotech Inc. (Sona) to improve lateral flow tests’ performance.

Reports cite, the collaboration aims to help accelerate the development of lateral flow immunoassays, also called as lateral flow tests, while also attempting to enhance their performance.

According to a press release by Sona Nanotech, under the collaboration, Sona would be supplying its innovative gold nanorod technology to the Australian firm, which would be combining it with its own proprietary technology, AnteoBind™ as well as several other biomarkers such as sepsis (CRP), cardic (cTnI) markers & HCG, a renowned fertility marker utilized in home pregnancy tests.

Through the collaboration, both firms intend to develop a number of reagent sets that would greatly benefit developers of lateral flow immunoassays across the world, boost test performance, lessen the production process timeframes and promote multiplexing.

The Chief Executive Officer of Anteo Diagnostics, Christopher Parker stated that with this partnership, the company would be using crucial point of care (POC) targets in the segments of sepsis, cardiac and pregnancy testing in an effort to assess the enhancements that could be brought to the tests. Parker further added the positive results of the collaboration would encourage global lateral flow test developers to readily adopt the firms’ co-developed products.

For the record, Immunoassays are easy and relatively inexpensive to manufacture, in a market that is worth over $6 billion according to a 2018 estimate. Over two billion such tests are produced across the world on a yearly basis.

According to reports, the financial information related to the collaboration agreement has not been unveiled yet.



About Author

Pankaj Singh

Email: [email protected]   linkdin twitter

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

More News By Pankaj Singh

The Bay collaborates with Rebelstork for gently used baby gear resale

The Bay collaborates with Rebelstork for gently used baby gear resale

By Pankaj Singh

Iconic retailer of Canada, The Bay has reportedly entered into a resale partnership with Rebelstork, a Canadian startup. Rebelstork is the first administered marketplace in North America for the resale of open box, qua...

Datopotamab Deruxtecan exhibits good tumor response in NSCLC patients

Datopotamab Deruxtecan exhibits good tumor response in NSCLC patients

By Pankaj Singh

According to new data for Dato-DXd (datopotamab deruxtecan), a DXd ADC (antibody drug conjugate) directed by TROP2 has reportedly showcased favorable tumor response rate in advanced NSCLC (non-small cell lung cancer) p...

Candy Club© reinforces retail commitment with new wholesale website

Candy Club© reinforces retail commitment with new wholesale website

By Pankaj Singh

Candy Club©, a growing candy brand that provides premium candy flavors with colorful packaging, has reportedly announced the launch of a new website for wholesale consumers to buy its products directly ...